Xiaobing Wu

Xiaobing Wu is an accomplished executive with extensive experience in the pharmaceutical industry. Currently serving as President, Chief Operating Officer, and General Manager for China at BeiGene since April 2018, Xiaobing Wu previously held the position of Country Manager at Pfizer for a brief period in April 2018. From May 2004 to October 2009, Xiaobing Wu was the President of Greater China at Wyeth Pharmaceutical. Earlier roles include General Manager at Bayer Healthcare Co. Ltd from April 2002 to May 2004 and positions in Sales and Marketing at Bayer from March 1992 to May 1996. Xiaobing Wu earned a Ph.D. in Molecular Biology from the University of Konstanz, attending from 1985 to 1992.